MiMedx Group, Inc.
MDXG
$7.22
$0.060.84%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 15.33% | 11.79% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 15.33% | 11.79% | |||
| Cost of Revenue | 0.20% | 12.82% | |||
| Gross Profit | 18.87% | 11.55% | |||
| SG&A Expenses | 7.56% | 6.97% | |||
| Depreciation & Amortization | 12.00% | 1.01% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 6.15% | 7.86% | |||
| Operating Income | 79.39% | 49.92% | |||
| Income Before Tax | 75.67% | 51.03% | |||
| Income Tax Expenses | 80.02% | 113.28% | |||
| Earnings from Continuing Operations | 74.13% | 36.95% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 74.13% | 36.95% | |||
| EBIT | 79.39% | 49.92% | |||
| EBITDA | 77.13% | 35.16% | |||
| EPS Basic | 73.73% | 36.48% | |||
| Normalized Basic EPS | 75.45% | 50.68% | |||
| EPS Diluted | 83.33% | 25.79% | |||
| Normalized Diluted EPS | 75.37% | 51.11% | |||
| Average Basic Shares Outstanding | 0.19% | 0.33% | |||
| Average Diluted Shares Outstanding | 0.27% | -0.24% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||